Leadership Core

$111,593U01FY2009DANIH

University Of California, San Francisco, San Francisco CA

Investigators

Linked publications, trials & patents

Paper 38097766 Paper 37802914 Paper 37059825 Paper 35639828 Paper 35227992 Paper 35190513 Paper 34847240 Paper 34599228 Paper 33873029 Paper 33772971 Paper 33675323 Paper 33300144 Paper 32686950 Paper 32224420 Paper 32157176 Paper 31502736 Paper 30946162 Paper 30852610 Paper 30815984 Paper 30649060 Paper 30627706 Paper 30614717 Paper 30535357 Paper 29986268 Paper 29853480 Paper 29232593 Paper 29232328 Paper 28921760 Paper 28884473 Paper 28728040 Paper 28556459 Paper 28553407 Paper 28181923 Paper 28178031 Paper 28148460 Paper 27964871 Paper 27865452 Paper 27815364 Paper 27712845 Paper 27187893 Paper 27180107 Paper 27113016 Paper 27035242 Paper 27030603 Paper 26875757 Paper 26872457 Paper 26833182 Paper 26805583 Paper 26407342 Paper 26392368 Paper 26355604 Paper 26317285 Paper 26272810 Paper 26132489 Paper 26069034 Paper 26014804 Paper 26010901 Paper 25991608 Paper 25895022 Paper 25794161 Paper 25732567 Paper 25655887 Paper 25588294 Paper 25555385 Paper 25436840 Paper 25416559 Paper 25277794 Paper 25187485 Paper 25143296 Paper 25012994 Paper 24980255 Paper 24948709 Paper 24781383 Paper 24733007 Paper 24667010 Paper 24548984 Paper 24448396 Paper 24402139 Paper 24305170 Paper 24186853 Paper 24052544 Paper 23999525 Paper 23946326 Paper 23941313 Paper 23936477 Paper 23933970 Paper 23884323 Paper 23872826 Paper 23824835 Paper 23714690 Paper 23692359 Paper 23681159 Paper 23669629 Paper 23623752 Paper 23594496 Paper 23591849 Paper 23588313 Paper 23462429 Trial NCT01314001 Trial NCT00791869

Abstract

The PNAT program will be led by the Leadership Core[unreadable]Drs. Ring, Benowitz, Swan and Toll. Drs. Ring and Benowitz will serve as co-principal investigators of the program, with responsibility for the execution of the research. The Leadership Core will make major program decisions, coordinate experimental approaches and procedures, and implement PGRN polices (See Section VTII.2 for detailed plans for program operation).

View original record on NIH RePORTER →